Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004226126 | SCV003743925 | uncertain significance | not specified | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.4579G>A (p.V1527M) alteration is located in exon 34 (coding exon 34) of the CHD1 gene. This alteration results from a G to A substitution at nucleotide position 4579, causing the valine (V) at amino acid position 1527 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003918999 | SCV004732975 | likely benign | CHD1-related disorder | 2022-03-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |